--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--------
--------
US Stock MarketDetailed Quotes
BCAX Bicara Therapeutics
- 19.710
- +0.515+2.68%
Trading Nov 19 10:39 ET
1.07BMarket Cap-18032P/E (TTM)
19.760High18.845Low27.38KVolume19.130Open19.195Pre Close526.58KTurnover0.16%Turnover RatioLossP/E (Static)54.42MShares28.09052wk High2.10P/B344.93MFloat Cap18.33052wk Low--Dividend TTM17.50MShs Float28.090Historical High--Div YieldTTM4.77%Amplitude18.330Historical Low19.230Avg Price1Lot Size
Bicara Therapeutics Key Stats
Bicara Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Bicara Therapeutics Earnings Reports
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
